Picture of CSL logo

CSL CSL Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Momentum

Relative Strength (%)
1m-9.73%
3m-14.36%
6m-8.98%
1yr-14.76%
Volume Change (%)
10d/3m+65.45%
Price vs... (%)
52w High-16.36%
50d MA-7.99%
200d MA-9.61%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)28.56
PEG Ratio (f)1.53
EPS Growth (f)22.92%
Dividend Yield (f)1.53%
Valuation (ttm)IndustryMarket
Price to Book Value5.49
Price to Tang. Bookn/a
Price to Free Cashflow138.51
Price to Sales7.35
EV to EBITDA28.19

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital9.15%
Return on Equity14.26%
Operating Margin24.32%

Financial Summary

Year End 30th JunUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue$m7,915.38,538.69,150.810,31010,561.913,287.0515,020.188.82%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+39.93+11.47+8.39+8.42-6.4+1.12+22.92n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202330th Jun 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of CSL EPS forecast chart

Profile Summary

CSL Limited (CSL) is an Australia-based biotechnology company. The Company’s areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Company’s CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Company’s geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

Directors

Last Annual
June 30th, 2022
Last Interim
December 31st, 2022
Incorporated
April 1st, 1991
Public Since
June 8th, 1994
No. of Shareholders
241,985
No. of Employees
30,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
482,216,193

CSL Share Price Performance

Upcoming Events for CSL

Full Year 2023 CSL Ltd Earnings Release

CSL Ltd Annual Shareholders Meeting

Similar to CSL

Picture of Acrux logo

Acrux

au flag iconAustralian Stock Exchange - SEATS

Picture of AFT Pharmaceuticals logo

AFT Pharmaceuticals

au flag iconAustralian Stock Exchange - SEATS

Picture of Auscann group logo

Auscann group

au flag iconAustralian Stock Exchange - SEATS

Picture of Biome Australia logo

Biome Australia

au flag iconAustralian Stock Exchange - SEATS

Picture of Botanix Pharmaceuticals logo

Botanix Pharmaceuticals

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email